ESMO Congress 2025

活動詳細資訊:

cancer treatment solutions. Backed by 800+ global oncology trials, Novotech returns to showcase our expertise, strengthen partnerships, and drive progress at every phase of cancer research. From solid tumors to leukemia, we support sponsors with end-to-end capabilities, including clinical operations, regulatory affairs, biostatistics, and project management, across regions to accelerate study startup, enrollment, and delivery.

Attendees:

• Barry Murphy, Chief Commercial Officer.
• Ian Braithwaite, VP - Global Project Management.
• Lotfi Rachedi, Director - Business Development.
• Sarah Anderson, Director - Therapeutic Strategy.
• Beata Zukovska, Project Director.

Schedule a meeting via the form on this page.